
|Articles|August 18, 2008
FDA clears Iridex IQ Laser Systems
Mountain view, Calif. - Iridex Corporation says it has received clearance from the U.S. Food and Drug Administration (FDA) for its IQ Laser Systems, according to BioOptics World.
Advertisement
Mountain view, Calif.
- Iridex Corporation says it has received clearance from the U.S. Food and Drug Administration (FDA) for its IQ Laser Systems, according to BioOptics World.
The clearance is for specific applications in dermatology as well as ophthalmology and ENT/otolaryngology. It covers the Iridex IQ 532 (green laser), IQ 577 (yellow), IQ 630-670 (red) and IQ 810 (infrared) laser products.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
5














